MedTrace Logo

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

NCT00002455 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Immunotherapy uses different ways to stimulate the immune system and stop cancer cells from growing. Immunotherapy biological extracts may be useful as adjuvant therapy in treating patients who have had surgery for breast cancer, colon cancer, or melanoma.

PURPOSE: Phase III trial to study the effectiveness of Corynebacterium granulosum extract as maintenance immunotherapy following surgery in treating patients with breast cancer, colon cancer, or melanoma.

Conditions

Interventions

BIOLOGICAL

Corynebacterium granulosum P40

PROCEDURE

adjuvant therapy

Sponsors & Collaborators

  • Centro Oncologico de Excelencia

    lead OTHER

Principal Investigators

  • Hugo Omar De Carli, MD · Centro Oncologico de Excelencia

Study Design

Purpose
TREATMENT

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1971-04-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002455 on ClinicalTrials.gov